Screening of Athletes
|ClinicalTrials.gov Identifier: NCT02056990|
Recruitment Status : Completed
First Posted : February 6, 2014
Last Update Posted : November 6, 2018
Athletes have to participate in screenings in order to reduce injuries. Up-to-now most screenings are purely clinically based. Literature, however, indicates the importance of knowledge on deviant movement patterns as possible risk factors for injuries. From this perspective, the current project aims to measure movement patterns, gait and running in young athletes to optimise training and prevent injuries.
2D- and 3d registration methods, force plate data and pressure plate data will be used to document the performance of the athletes.
|Condition or disease||Intervention/treatment|
|Individual Differences Motor Activities||Other: Advice|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||15 participants|
|Target Follow-Up Duration:||2 Years|
|Official Title:||Screening of Athletes for Prevention of Injury and Optimisation of Performance|
|Study Start Date :||March 2014|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
- Kinematic and kinetic data [ Time Frame: March - June 2014 (3 months) ]
Angles at different joints will be investigated with 3D movement analysis methods. Kinetic data (joint moments) will be calculated with 3D movement analysis methods.
Center of pressure measures will be calculated on the basis of force plate data.
Gait, running, jumps, postural balance will be investigated. Plantar pressure parameters will be calculated on the basis of plantar pressure measurements.
- 2 D parameters [ Time Frame: March - June 2014 (3 months) ]Video analysis methods (Dartfish) will be used to calculate joint angles during jumps
- Sports activities,personal demographics, injury history [ Time Frame: March - June 2014 (3 months) ]Sports activities, personal demographics and injury history will be documented through existing information from the medical department (Physical Rehabilitation of University Hospitals Leuven)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02056990
|Leuven, Vlaams-Brabant, Belgium, 3000|
|Principal Investigator:||Filip F Staes, Professor||KU Leuven|